Latest Issue
EDITOR'S DESK
Editor's Desk
-
Political scientists: The danger of mixing pharma with politics
EPM editor Reece Armstrong examines why political meddling in pharma can harm the industry. Read more
-
The steps taken: Why clinical trials have a diversity problem
European Pharmaceutical Manufacturer editor Reece Armstrong looks at the issue of diversity in clinical trials and how medicines aren't developed with every patient in mind. Read more
-
Lessons learned: The questions to ask after Covid-19
With countries around the world beginning to consider steps to ease their lockdown restrictions now may be the best time to look at the lessons we should have learned from the Covid-19 crisis. Read more
-
_cb-f757a826aacf79ad332cd85473511439-w-640.jpg "Coronavirus")
Why Covid-19 could change how pharma and government work together
Whilst the outbreak of the latest strain of Coronavirus – Covid-19 – is a scare for healthcare systems and citizens worldwide, it presents an opportunity to pharma and government to reassess the way they work together. Read more
LATEST ISSUE
Download Corner
Read now! EPM November/December 2020
The November/December issue of EPM is available for download, with all the regulars and features on women in pharma, lyophilisation, testing & inspection and more. Read more
Read now! EPM September/October 2020
The September/October issue of EPM is available for download, with all the regulars and features on contract manufacturing, lab automation, formulation and more. Read more
Read now! EPM June/July/August 2020
The June/July/August issue of EPM is available for download, with all the regulars and features on drug delivery, packaging and Covid-19. Read more
Read now! EPM May 2020
The May issue of EPM is available for download, with all the regulars and features on anti-counterfeiting, lyophilisation, and Covid-19. Read more
Read now! EPM March/April 2020
The March/April issue of EPM is available for download with all the regulars and features on logistics & distribution, single use systems, women in pharma and Covid-19. Read more